deguelin has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, XJ; He, RZ; Li, X; Peng, F; Qin, RY; Shen, M; Shi, CJ; Shi, XH; Wang, M; Wang, X; Xu, XD; Zhang, M; Zhao, Y | 1 |
| Boreddy, SR; Srivastava, SK | 1 |
2 other study(ies) available for deguelin and Cancer of Pancreas
| Article | Year |
|---|---|
Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin.
Topics: Anticarcinogenic Agents; Apoptosis; Autophagy; Biomarkers; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Pancreatic Neoplasms; Rotenone | 2017 |
Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.
Topics: Animals; Blotting, Western; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Mice; Mice, Nude; Models, Genetic; Neoplasm Metastasis; NF-kappa B; Pancreas; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta1; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |